[HTML][HTML] Small molecule-based treatment approaches for intervertebral disc degeneration: current options and future directions

A Kamali, R Ziadlou, G Lang, J Pfannkuche, S Cui… - Theranostics, 2021 - ncbi.nlm.nih.gov
Low back pain (LBP) is a major reason for disability, and symptomatic intervertebral disc
(IVD) degeneration (IDD) contributes to roughly 40% of all LBP cases. Current treatment …

Biologic treatment of mild and moderate intervertebral disc degeneration

ES Vasiliadis, SG Pneumaticos, DS Evangelopoulos… - Molecular …, 2014 - Springer
Disc degeneration is the most common cause of back pain in adults and has enormous
socioeconomic implications. Conservative management is ineffective in most cases, and …

Fundamentals of intervertebral disc degeneration

S Kirnaz, C Capadona, T Wong, JL Goldberg… - World neurosurgery, 2022 - Elsevier
Lumbar disc degeneration is one of the leading causes of chronic low back pain. The
degenerative cascade is often initiated by an imbalance between catabolic and anabolic …

Strategies for regeneration of the intervertebral disc

NS Kalson, S Richardson, JA Hoyland - Regenerative medicine, 2008 - Taylor & Francis
Low back pain resulting from degenerative disc disease is the most common cause of
disability in the UK. Current low back pain treatments are aimed at either treating the …

Recent advances in managing spinal intervertebral discs degeneration

B Costăchescu, AG Niculescu, RI Teleanu… - International journal of …, 2022 - mdpi.com
Low back pain (LBP) represents a frequent and debilitating condition affecting a large part of
the global population and posing a worldwide health and economic burden. The major …

Current trends in biologics delivery to restore intervertebral disc anabolism

G Fontana, E See, A Pandit - Advanced drug delivery reviews, 2015 - Elsevier
Low back pain is generally attributed to intervertebral disc (IVD) degeneration. This is a
multifactorial disease induced by genetic and environmental factors and that progresses …

Molecular therapy of the intervertebral disc

ST Yoon, NM Patel - European Spine Journal, 2006 - Springer
Disc degeneration is the loss of the normal nucleus pulposus disc matrix to a more fibrotic
and less cartilaginous structure. This change in disc micro-anatomy can be associated with …

Advancing the cellular and molecular therapy for intervertebral disc disease

D Sakai, S Grad - Advanced drug delivery reviews, 2015 - Elsevier
The healthy intervertebral disc (IVD) fulfils the essential function of load absorption, while
maintaining multi-axial flexibility of the spine. The interrelated tissues of the IVD, the annulus …

Biological treatment strategies for disc degeneration: potentials and shortcomings

G Paesold, AG Nerlich, N Boos - European Spine Journal, 2007 - Springer
Recent advances in molecular biology, cell biology and material sciences have opened a
new emerging field of techniques for the treatment of musculoskeletal disorders. These new …

Targeting oxidative stress and inflammation in intervertebral disc degeneration: therapeutic perspectives of phytochemicals

L Kang, H Zhang, C Jia, R Zhang… - Frontiers in pharmacology, 2022 - frontiersin.org
Low back pain is a major cause of disability worldwide that declines the quality of life; it
poses a substantial economic burden for the patient and society. Intervertebral disc (IVD) …